Key points are not available for this paper at this time.
ATP III metabolic syndrome criteria may identify high-risk individuals; leaves open incremental predictive value beyond components in prospective data.
The National Cholesterol Education Program Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III [ATP III]) recently proposed a formal definition of the metabolic (insulin resistance) syndrome (1). For the purposes of ATP III, metabolic syndrome is present when ≥3 of the following determinations are present: waist circumference >102 or >88 cm in men and women, respectively; triglycerides ≥150 mg/dl; HDL cholesterol <40 or <50 mg/dl in men and women, respectively; blood pressure ≥130/≥85 mmHg; and fasting glucose ≥110 mg/dl. Data from the Third National Health and Nutrition Examination Survey (NHANES III) show that among U.S. adults ≥20 years of age, metabolic …
No takes yet. Share an insight, caveat, or question.
Helaine E. Resnick (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: